Enterococci are an important group of potentially pathogenic bacteria whose taxonomy has changed considerably in the last few years. To date, 12 enterococcal species have been described, and recently Facklam and Collins (4) have proposed an identification procedure for differentiating the species which is based on conventional biochemical tests. Some of the more recently described species have been isolated only rarely from clinical specimens.
In the present report, we describe two strains of Enterococcus mundtii, and this is to our knowledge the first detailed description of their isolation from normally sterile body sites. These strains were originally identified as Enterococcus faecium by a commercially available identification system and were also incorrectly identified as Enterococcus faecalis by another commercial system. Case 1. A 44-year-old female had a history of a severe, steroid-dependent rheumatoid arthritis with multiple joint involvements. Therefore, several surgeries were necessary, including a right total hip arthroplasty in 1978.
In March 1985, the patient was admitted again for evaluation of fevers with chills. Laboratory studies showed a leukocytosis of 88,000 cells per mm3, with a shift to immature neutrophils. Despite empirical antibiotic therapy with trimethoprim-sulfamethoxazole plus nafcillin, the patient remained febrile. Several blood cultures were sterile. One week after the hospital admission, an abscess of the right thigh became apparent and a debridement was carried out. Staphylococcus aureus and an Enterococcus sp. (originally identified as E. faecium) were isolated from the intraoperatively obtained tissue. Nafcillin and penicillin were given intravenously for 10 days, and the patient rapidly became afebrile.
In June 1985, the patient became febrile again and underwent removal of the acetabular component of the total hip arthroplasty, with placement of tobramycin beads. Intraoperative cultures again yielded S. aureus and an Enterococcus species with antibiograms identical to those for the previous isolates. An additional course of trimethoprim-sulfamethoxazole plus cefazolin was given intravenously and was associated with a complete recovery. complicated by multiple febrile episodes and a lack of engraftment. Despite broad-spectrum antibiotic therapy with various regimens including vancomycin, tobramycin, clindamycin, ticarcillin, cefotaxime, and amphotericin B, the patient remained febrile. Because a chronic sinusitis was considered a possible focus of infection, bilateral nasal antral windows were made. The operatively obtained culture material from the left sinus showed light growth of an alphahemolytic oral streptococcus (species identification was not done) and light growth of an Enterococcus sp. (originally identified as E. faecium), but no anaerobic bacteria were found. The histological examination of the removed sinus mucosa revealed no evidence for a pathological process. During the later clinical course, two further attempts of bone marrow transplantation were unsuccessful, and finally the boy died from progressive encephalopathy and respiratory arrest. At the autopsy, no specific cause of death was identified.
The isolates of both cases were confirmed as enterococci by established routine methods; both strains were catalase negative, they grew in the presence of 6.5% NaCl at 10 and 45°C, and they were positive for pyrrolidonylarylamidase activity and for Lancefield group D antigen (Phadebact; Pharmacia). The species differentiation with the GPI card (Vitek Systems, Inc., Hazelwood, Mo.) led originally to the identification E. faecium with a 99% probability in both cases (code number 77727370160 for case 1 and code number 77727270160 for case 2). With this system, both strains were esculin, lactose, mannitol, trehalose, and arabinose positive; they were raffinose and inulin negative. One strain was sorbitol positive, and the other strain was sorbitol negative.
Later testing with the API 20S Streptococcus System (Analytab Products, Plainview, N.Y.) gave the result E. faecalis in both cases (profile number 7702741, "excellent identification" for both). Both strains gave a negative raffinose test; arabinose utilization is not included in the API 20S. Other key reactions included acid formation from mannitol, sorbitol, glycerol, lactose, trehalose, and sucrose. The strains were bile esculin positive, utilized arginine, and were negative for hippurate hydrolysis.
The two isolates were nonhemolytic and yellow pigmented on 5% sheep blood agar plates. Of note, they were nonmotile. Further from E. faecalis and E. faecium were arabinose, sorbitol, and raffinose utilization. The MICs of several relevant antibiotics were determined by a standardized agar dilution method employing MuellerHinton agar (7) ( Table 2 ). Testing was not done for trimethoprim-sulfamethoxazole since this drug is not considered effective therapy for enterococcal infections.
Although the strains have been known since 1950 (6), the taxonomy of yellow-pigmented enterococcal strains was equivocal until recently, when they were isolated in greater numbers from soil (9) and plants (10) . Some of these strains are motile and belong to the taxon Enterococcus casseliflavus, which was proposed in 1984 (2) . In 1986, Collins et al.
(1) described a new enterococcal species, E. mundtii, which encompasses yellow-pigmented nonmotile strains. The division of the yellow-pigmented enterococcal isolates into two distinct groups was supported by their different DNA base compositions. The guanine-plus-cytosine (G+C) content of E. casseliflavus ranged from 42 to 45 mol%, in contrast to that of strains belonging to E. mundtii, which had a G+C content of 38 to 39 mol%. Furthermore, DNA-DNA hybridization studies showed that strains of E. mundtii segregated into a homology group that distinguished them clearly from other enterococcal species.
Two other nonmotile, yellow-pigmented streptococcal 
